Molecular deficiency (ies) in MT1 melatonin signaling pathway underlies the melatonin-unresponsive phenotype in MDA-MB-231 human breast cancer cells

Journal of Pineal Research

Volumn 56, Issue 3, 2014, Pages 246-253

  Mao, Lulu ^a   Yuan, Lin ^a   Xiang, Shulin ^a   Zeringue, Samantha B ^a   Dauchy, Robert T ^a   Blask, David E ^a   Hauch, Adam ^a   Hill, Steven M ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

melatonin; melatonin receptor (MT1)

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; MELATONIN; MELATONIN 1 RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR ALPHA, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CELL STRAIN; CELL STRAIN BT 20; CELL STRAIN MDA MB 231; CELL STRAIN SK BR 3; CONTROLLED STUDY; HUMAN; HUMAN CELL; PHENOTYPE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; CELL PROLIFERATION; DRUG EFFECTS; FEMALE; GENETICS; METABOLISM; PHYSIOLOGY; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL PROLIFERATION; ESTROGEN RECEPTOR ALPHA; FEMALE; HUMANS; MELATONIN; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHENOTYPE; RECEPTOR, MELATONIN, MT1; SIGNAL TRANSDUCTION;

EID: 84896129902     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/jpi.12117     Document Type: Article

References (36)

1. Vanecek J,. Cellular mechanisms of melatonin action. Physiol Rev 1998; 78: 687-721.
2. Hardeland R, Madrid JA, Tan DX, et al. Melatonin, the circadian multioscillator system and health: the need for detailed analyses of peripheral melatonin signaling. J Pineal Res 2012; 52: 139-166.
3. Cardinali DP, Srinivasan V, Brzezinski A, et al. Melatonin and its analogs in insomnia and depression. J Pineal Res 2012; 52: 365-375.
4. Barrett P, Bolborea M,. Molecular pathways involved in seasonal body weight and reproductive responses governed by melatonin. J Pineal Res 2012; 52: 376-388.
5. Reppert SM, Weaver DR, Ebisawa T,. Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses. Neuron 1994; 13: 1177-1185.
6. Zhao H, Poon AM, Pang SF,. Pharmacological characterization, molecular subtyping, and autoradiographic localization of putative melatonin receptors in uterine endometrium of estrous rat. Life Sci 2000; 66: 1581-1591.
7. Witt-Enderby PA, Masana MI, Dubocovich ML,. Physiological exposure to melatonin supersensitizes the cyclic adenosine 3′,5′-monophosphate- dependent signal transduction cascade in Chinese hamster ovary cells expressing the human mt1 melatonin receptor. Endocrinol 1998; 139: 3064-3071.
8. Burns DM, Cos CS, Blask DE,. Demonstration and partial characterization of 2-iodomelatonin binding sites in experimental mammary carcinoma. Program of the 72nd annual meeting of the endocrine society, 1990. San Antonio, TX, p 62 (abstract).
9. Blask DE, Pelletier DB, Hill SM, et al. Pineal melatonin inhibition of tumor promotion in the N-nitroso-N-methylurea of mammary carcinogenesis: potential involvement of antiestrogenic mechanisms in vivo. J Cancer Res Clin Oncol 1990; 117: 526-532.
10. Ram PT, Kiefer TL, Silverman M, et al. Estrogen receptor transactivation in MCF-7 breast cancer cells by melatonin and growth factors. Mol Cell Endocrinol 1998; 141: 53-64.
11. Reppert SM, Godson C, Mahel CD, et al. Molecular characterization of a second melatonin receptor expressed in human retina and brain: the Mel(1b) melatonin receptor. Proc Natl Acad Sci USA 1995; 92: 8734-8738.
12. Reppert SM, Weaver DR, Godson C,. Melatonin receptor step into light: cloning and classification of subtypes. Trends Pharmacol Sci 1996; 17: 100-102.
13. Nowfar S, Teplitzky SR, Melancon K, et al. Tumor prevention by 9-cis-retinoic acid in the N-nitroso-N-methylurea model of mammary carcinogenesis is potentiated by the pineal hormone melatonin. Breast Cancer Res Treat 2002; 72: 33-43.
14. Hill SM, Spriggs LL, Simon MA, et al. The growth inhibitory action of melatonin on human breast cancer cells is linked to the estrogen response system. Cancer Lett 1992; 64: 249-256.
15. Blask DE, Hill SM,. Effects of melatonin on cancer: studies on MCF-7 human breast cancer cells in culture. J Neural Transm Suppl 1986; 21: 433-449.
16. Hill SM, Blask DE,. Effects of the pineal gland hormone, melatonin, on the proliferation and morphological characteristics of human breast cancer cells (MCF-7) in culture. Cancer Res 1988; 48: 6121-6128.
17. Yuan L, Collins AR, Dai J, et al. MT(1) melatonin receptor overexpression enhances the growth suppressive effect of melatonin in human breast cancer cells. Mol Cell Endocrinol 2002; 192: 147-156.
18. Collins A, Yuan L, Kiefer TL, et al. Overexpression of the MT1 melatonin receptor in MCF-7 human breast cancer cells inhibits mammary tumor formation in nude mice. Cancer Lett 2003; 189: 49-57.
19. Xiang S, Mao L, Yuan L, et al. Impaired mouse mammary gland growth and development is mediated by melatonin and its MT1 G protein-coupled receptor via repression of ERα, Akt1, and Stat5. J Pineal Res 2012; 53: 307-318.
20. Blask DE, Brainard GC, Dauchy RT, et al. Melatonin-depleted blood from premenopausal women exposed to light at night stimulates growth of human breast cancer xenografts in nude rats. Cancer Res 2005; 65: 11174-11184.
21. Mao L, Dauchy RT, Blask DE, et al. Circadian gating of epithelial-to-mesenchymal transition in breast cancer cells via melatonin-regulation of GSK3β. Mol Endocrinol 2012; 26: 1808-1820.
22. Ram PT, Dai J, Yuan L, et al. Involvement of the mt1 melatonin receptor in human breast cancer. Cancer Lett 2002; 179: 141-150.
23. Kiefer TL, Lai L, Yuan L, et al. Differential regulation of estrogen receptor alpha, glucocorticoid receptor and retinoic acid receptor alpha transcriptional activity by melatonin is mediated via different G proteins. J Pineal Res 2005; 38: 231-239.
24. Lai L, Yuan L, Chen Q, et al. The Galphai and Galphaq proteins mediate the effects of melatonin on steroid/thyroid receptor transcriptional activity and breast cancer cell proliferation. J Pineal Res 2008; 45: 476-488.
25. Brydon L, Roka F, Petit L, et al. Dual signaling of human Mel1a melatonin receptors via Gi2, Gi3, Gq/11 proteins. Mol Endocrinol 1999; 13: 2025-2038.
26. Chan AS, Lai FP, Lo RK, et al. Melatonin mt1 and MT2 receptors stimulate c-Jun N-terminal kinase via pertussis toxin-sensitive and -insensitive G proteins. Cell Signal 2002; 14: 249-257.
27. Stork PJ, Schmitt JM,. Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation. Trends Cell Biol 2002; 12: 258-266.
28. Dumaz N, Marais R,. Integrating signals between cAMP and the RAS/RAF/MEK/ERK signalling pathways. Based on the anniversary prize of the Gesellschaft fur Biochemie und Molekularbiologie Lecture delivered on 5 July 2003 at the Special FEBS Meeting in Brussels. FEBS J 2005; 272: 3491-3504.
29. Molis TM, Spriggs LL, Jupiter Y, et al. Melatonin modulation of estrogen-regulated proteins, growth factors, and proto-oncogenes in human breast cancer. J Pineal Res 1995; 18: 93-103.
30. Molis TM, Spriggs LL, Hill SM,. Modulation of estrogen receptor mRNA expression by melatonin in MCF-7 human breast cancer cells. Mol Endocrinol 1994; 8: 1683-1690.
31. Hill SM, Blask DE, Xiang S, et al. Melatonin and associated signaling pathways that control normal breast epithelium and breast cancer. J Mammary Gland Biol Neoplasia 2011; 16: 235-245.
32. Jung JH, Sohn EJ, Shin EA, et al. Melatonin Suppresses the Expression of 45S Preribosomal RNA and Upstream Binding Factor and Enhances the Antitumor Activity of Puromycin in MDA-MB-231 Breast Cancer Cells. Evid Based Complement Alternat Med 2013; 2013: 879746.
33. Cabrera-Vera TM, Vanhauwe J, Thomas TO, et al. Insights into G protein structure, function, and regulation. Endocr Rev 2003; 24: 765-781.
34. Kiefer TL, Yuan L, Ram PT, et al. Melatonin inhibits estrogen receptor transactivation and cAMP levels in MCF-7 human breast cancer cells. Breast Cancer Res Treat 2002; 71: 37-45.
35. Morgan PJ, Lawson W, Davidson G, et al. Guanine nucleotides regulate the affinity of melatonin receptors in the ovine pars tuberalis. Neuroendocrinol 1989; 50: 359-362.
36. Ishido M, Nitta H, Kabuto M,. Magnetic fields (MF) of 50 Hz at 1.2 microT as well as 100 microT cause uncoupling of inhibitory pathways of adenylyl cyclase mediated by melatonin 1a receptor in MF-sensitive MCF-7 cells. Carcinogenesis 2001; 22: 1043-1048.